ArcherDx bought by Mass. company
Last Updated: 15:16 September 6, 2013
Boulder-based ArcherDx is expected to grow to 15 or 20 employees from its current 10 following the announcement from Beverly, Massachusetts-based Enzymatics, a DNA sequencing company. ArcherDx's research and development is expected to remain in Boulder, while future manufacturing is expected to be done in Massachusetts, said Charles Liles, an Enzymatics spokesman.
ArcherDx makes diagnostic kits and analytical software to help hospitals and researchers assess genetic information from patients, according to a company press statement. Jason Myers, an ArcherDx co-founder, will join Enzymatics as chief scientific officer, according to the press statement.
In the future, ArcherDx products may be used to develop a diagnostic test that can help determine the most appropriate cancer treatment for some patients, Liles said. DNA sequencing research has taken off in recent years as scientists search for new cures for diseases.
More breaking news...
WhiteWave buying Earthbound Farm
Jobs grant will aid flood-impacted counties
Broomfield-based WhiteWave (NYSE: WWAV) said the deal is expected to close in the first
Job growth to continue in state next year
About 230 temporary workers will be hired to clean up and repair areas in